Aspirin Dosing in Cardiovascular Disease

被引：1
|
作者：
Monach, Paul A. [1 ]
Branch-Elliman, Westyn [1 ]
机构：
[1] VA Boston Healthcare Syst, Boston, MA 02130 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 385卷 / 08期
关键词：
D O I：
10.1056/NEJMc2110476
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 764
页数：1
相关论文
共 50 条
  • [31] Aspirin for Prevention and Treatment of Cardiovascular Disease
    Mehta, Shamir R.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (06) : 414 - 416
  • [32] Reasons for resistance to aspirin in cardiovascular disease
    Szczeklik, A
    Musial, J
    Undas, A
    CIRCULATION, 2002, 106 (22) : E181 - E181
  • [33] Aspirin resistance in cardiovascular disease: A review
    Wong, S
    Appleberg, M
    Ward, CM
    Lewis, DR
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2004, 27 (05) : 456 - 465
  • [34] Aspirin for primary prevention of cardiovascular disease
    Nansseu J.R.N.
    Noubiap J.J.N.
    Thrombosis Journal, 13 (1)
  • [35] Aspirin for secondary prevention of cardiovascular disease
    Byrne, Robert A.
    Colleran, Roisin
    LANCET, 2020, 395 (10235): : 1462 - 1463
  • [36] Inflammation, aspirin, and the risk of cardiovascular disease
    Bruno, JJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06): : 422 - 422
  • [37] Aspirin in the treatment and prevention of cardiovascular disease
    Hennekens, CH
    ANNUAL REVIEW OF PUBLIC HEALTH, 1997, 18 : 37 - 49
  • [38] Aspirin for primary prevention of cardiovascular disease
    Waltering, A
    Hemkens, L
    Florack, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (49) : 2847 - 2852
  • [39] Aspirin in the treatment and prevention of cardiovascular disease
    Gaziano, JM
    Skerrett, PJ
    Buring, JE
    HAEMOSTASIS, 2000, 30 : 1 - 13
  • [40] The role of aspirin in cardiovascular disease prevention
    Wagenaar, Peter
    CARDIOVASCULAR JOURNAL OF AFRICA, 2012, 23 (05) : 300 - 300
12345